Metformin-induced encephalopathy without lactic acidosis in a patient with contraindication for metformin

Hemodialysis International

Volumn 13, Issue 2, 2009, Pages 172-175

  Jung, Eun Young ^a   Cho, Hyun Seop ^b   Seo, Jong Woo ^b   Kim, Dong Wook ^b   Kim, Hyun Jung ^b   Chang, Se Ho ^b   Park, Dong Jun ^b  

^a Good Sam Jung Hospital   (South Korea)

^b Gyeongsang National University School of Medicine   (South Korea)

Author keywords

Encephalopathy; Hemodialysis; Metformin

Indexed keywords

ACETYLSALICYLIC ACID; AMLODIPINE BESYLATE; INSULIN; METFORMIN; VITAMIN;

ADULT; ARTICLE; BRAIN DISEASE; CASE REPORT; CLINICAL FEATURE; DIABETES MELLITUS; DISEASE ASSOCIATION; DRUG CONTRAINDICATION; DRUG WITHDRAWAL; DYSARTHRIA; GAIT DISORDER; HEMODIALYSIS; HUMAN; KIDNEY FAILURE; KOREA; LACTIC ACIDOSIS; LEUKOCYTE COUNT; MALE; MYOCLONUS; NUCLEAR MAGNETIC RESONANCE IMAGING;

ACIDOSIS, LACTIC; BRAIN DISEASES; DIABETES MELLITUS, TYPE 1; DIABETIC NEPHROPATHIES; HUMANS; HYPOGLYCEMIC AGENTS; KIDNEY FAILURE, CHRONIC; MAGNETIC RESONANCE IMAGING; MALE; METFORMIN; MIDDLE AGED; RENAL DIALYSIS;

EID: 65449122761     PISSN: 14927535     EISSN: 15424758     Source Type: Journal    
DOI: 10.1111/j.1542-4758.2009.00358.x     Document Type: Article

References (17)

1. Bailey CJ. Biguanides and NIDDM. Diabetes Care. 1992; 15: 755-772.
2. Richard WS, Jeffrey SB. Use of insulin and oral hypoglycemic medications in patients with diabetes mellitus and advanced kidney disease. Semin Dial. 2004; 17: 365-370.
3. Chang CT, Chen YC, Fang JT, Haung CC. Metformin-associated lactic acidosis: Case reports and literature review. J Nephrol. 2002; 15: 398-402.
4. Latau JD, Race JM. Lactic acidosis in metformin therapy. Drugs. 1999; 58: 75-82.
5. Ben-Ami H, Nagachandran P, Mendelson A, Edoute Y. Drug-induced hypoglycemic coma in 102 diabetic patients. Arch Intern Med. 1999; 159: 281-284.
6. Rasuli P, Hammond DI. Metformin and contrast media: Where is the conflict? Can Assoc Radiol J. 1998; 49: 161-166.
7. Chan KA, Truman A, Gurwitz JH, et al. A cohort study of the incidence of serious acute liver injury in diabetic patients treated with hypoglycemic agents. Arch Intern Med. 2003; 163: 728-734.
8. Vander T, Hallevy H, Ifergane G, Herishanu YO. Metformin-induced encephalopathy without lactic acidosis. Diabetes UK. Diabetic Med. 2003; 21: 194-198.
9. Nisber JC, Sturtevant JM, Parins JB. Metformin and serious adverse effects. Med J Aust. 2004; 180: 53-54.
10. Alivanis P, Giannikouris I, Paliuras C, Aravanitis A, Volanaki M, Zervos A. Metformin-associated lactic acidosis treated with continuous renal replacement therapy. Clin Ther. 2006; 28: 396-400.
11. Kirpichnikov D, McFarlane SI, Sowers JR. Metformin: An update. Ann Intern Med. 2002; 137: 25-33.
12. Heaney D, Majid A, Junor B. Bicarbonate hemodialysis as a treatment of metformin overdose. Nephrol Dial Transplant. 1997; 12: 1046-1047.
13. Alivanis P, Giannikouris I, Paliuras C, Aravanitis A, Volanaki M, Zervos A. Metformin-associated lactic acidosis treated with continuous renal replacement therapy. Clin Ther. 2006; 28: 396-400.
14. Gan SC, Barr J, Arieff AI, Pearl RG. Biguanid-associated lactic acidosis. Case report and review of the literature. Arch Intern Med. 1992; 152: 2333-2336.
15. Lalau JD, Westeel PF, Debussche X, et al. Bicarbonate hemodialysis: An adequate treatment for lactic acidosis in diabetic treated by metformin. Intensive Care Med. 1987; 13: 383-387.
16. Agildere AM, Kurt A, Yildirim T, Benli S, Altinors N. MRI of neurologic complications in end-stage renal failure patients on hemodialysis: Pictorial review. Eur Radiol. 2001; 11: 1063-1069.
17. Kunze K. Metabolic encephalopathies. J Neurol. 2002; 249: 1150-1159.